3 completed. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
Follow Hemoptysis: new trials by email Literature Review of Hemoptysis trials Research Report on Hemoptysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tranexamic Acid : Nebulization vs IV Route for Hemoptysis Tranexamic Acid (TXA) - Hemoptysis, NEBULIZATION | Phase 2 / Phase 3 | Completed | University of Health Sciences Lahore | 172 | 2025-08-01 | 2025-11-28 |
| Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies Topical epinephrine, Placebos - Lung Transplant; Complications, Mechanical, Lung Transplant; Complications | Phase 2 / Phase 3 | Completed | University of Maryland, Baltimore | 66 | 2017-07-01 | 2024-08-28 |
| Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab bevacizumab, paclitaxel, carboplatin - Adenosquamous Cell Lung Cancer, Drug/Agent Toxicity by Tissue/Organ | Phase 2 | Completed | National Cancer Institute (NCI) | 72 | 2006-10-01 | 2013-01-17 |
Carcinoma, Non-Small-Cell Lung (1) · Drug-Related Side Effects and Adverse Reactions (1) · Hemorrhage (1)
Lung Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Respiratory Tract Diseases (3) · Signs and Symptoms (3) · Signs and Symptoms, Respiratory (3) · Hemorrhage (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Chemically-Induced Disorders (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Bevacizumab (1) · Carboplatin (1) · Epinephrine (1) · Paclitaxel (1) · Radiation (1) · Radiotherapy (1) · Taxes (1) · Tranexamic Acid (1)
National Cancer Institute (NCI) (1) · University of Health Sciences Lahore (1) · University of Maryland, Baltimore (1)
Pakistan (1) · United States (1)
Robert M Reed, MD (1) · Zelanna Goldberg (1)
PMID 30904852, PMID 36410494, PMID 37140517
N01CM62201 (1), N01CM62203 (1), N01CM62208 (1), N01CM62209 (1)